Company news

Crescita Therapeutics, Inc. news in 2019

Crescita Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Crescita Reports 2019 Third Quarter Results

November 7, 2019

U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

November 5, 2019

Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

October 28, 2019

Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

September 5, 2019

Crescita Reports Profitable 2019 Second Quarter Results

August 8, 2019

United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®

July 16, 2019

Crescita Therapeutics to Host Investor Webcast on July 24, 2019

July 11, 2019

Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of Euro1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy

July 4, 2019

Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer Bid

June 17, 2019

Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California

May 30, 2019

Crescita Therapeutics Engages Bristol Capital to Provide Investor Relations and Communications Services

May 29, 2019

Crescita Therapeutics Reports 2019 First Quarter Results

May 15, 2019

Crescita Therapeutics Strengthens Leadership Team with New Vice-President in Aesthetic and Cosmeceutical Business Unit

May 7, 2019

Crescita Therapeutics Signs Pliaglis® Out-Licensing Agreement with Cantabria Labs for Euro2.5M Upfront After Reacquiring Rest-of-World Rights

April 25, 2019

Crescita Therapeutics to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto

April 17, 2019

Crescita Therapeutics Reports Fourth Quarter and Fiscal 2018 Results Record Annual Revenue of $16.6M and Adjusted EBITDA of $1.5M Strong Royalties and Sales Milestones

March 21, 2019

Crescita Therapeutics Inc.(TM) and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra's Dermatology Product Portfolio

February 4, 2019